When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
Cancer detection startup Grail today filed to go public as the Silicon Valley biotech aims to raise more funding for its blood test. The company’s backers include Microsoft co-founder Bill… Read More
— The former head of Juno Therapeutics, Hans Bishop, signed on as CEO of Grail, a Bay Area biotech focused on the early detection of cancer. Bishop replaces former Grail… Read More
News Brief: Grail, a biotech company with early backing from Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos, says it’s raised $300 million in an oversubscribed Series C financing… Read More
One of the giants of gene sequencing, Illumina, has spun off a new $100 million company called Grail to create an all-in-one blood test for cancer – and its investors include… Read More